目前的现金情况:Q1 Cash Balance of $156.9M
计划可以支撑到:Q3 2019
潜在的几笔收入:
Anti-TIGIT: Potential $35 million following the completion of our ongoing Phase 1a clinical trial.
Rosmantuzumab (Anti-RSPO3): Potentia...查看全文
洗瓶子的老药工2017-05-05 21:09
$ONCOMED PHARMACEUTICALS INC(OMED)$
May 4, 2017
OncoMed Doses First Patient with Anti-TIGIT Antibody in Phase 1 Clinical Trial
终于开始临床试验了,似乎是全球第二个,今天资本市场怎么看?毫无反应?查看全文
洗瓶子的老药工2017-05-04 16:43
$ONCOMED PHARMACEUTICALS INC(OMED)$ 昨天跌了不少,可是没有看到什么明确的利空。只是说要开个一季度的财报会议。这种公司才是创新型企业,风险真高。和A股伪创新、H股老千完全不是一个玩法,小心小心再小心。风控第一。查看全文
$OptMed(OMED)$ RW Registration Withdrawal Request Accession Number: 0000897069-23-000718 Act: NE Size: 6 KB 网页链接
$OptMed(OMED)$ S-1/A [Amend] General form for registration of securities under the Securities Act of 1933 Accession Number: 0001493152-22-020351 Act: 33 Size: 3 MB 网页链接
$Oncomed制药(OMED)$ S-1 General form for registration of securities under the Securities Act of 1933 Accession Number: 0001493152-22-016871 Act: 33 Size: 44 MB 网页链接
$Oncomed制药(OMED)$ 15-12B - Securities registration termination [Section 12(b)] Filed: 2019-05-03 AccNo: 0000950103-19-005954 Size: 11 KB 网页链接
$Oncomed制药(OMED)$ SC 13D/A [Amend] - General statement of acquisition of beneficial ownership Filed: 2019-04-26 AccNo: 0000921895-19-001178 Size: 202 KB 网页链接
$Oncomed制药(OMED)$ S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments Filed: 2019-04-24 AccNo: 0000950103-19-005050 Size: 22 KB 网页链接
$Oncomed制药(OMED)$ S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments Filed: 2019-04-24 AccNo: 0000950103-19-005051 Size: 22 KB 网页链接
$Oncomed制药(OMED)$ S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments Filed: 2019-04-24 AccNo: 0000950103-19-005052 Size: 22 KB 网页链接
$Oncomed制药(OMED)$ S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments Filed: 2019-04-24 AccNo: 0000950103-19-005053 Size: 22 KB 网页链接
$Oncomed制药(OMED)$ S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments Filed: 2019-04-24 AccNo: 0000950103-19-005054 Size: 22 KB 网页链接